Detalhe da pesquisa
1.
CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM.
Am J Hematol
; 99(5): 1001-1004, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38404143
2.
Transfusion-Transmitted Hepatitis A Virus, France, 2018.
Emerg Infect Dis
; 28(1): 219-223, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34932935
3.
Sequential mutational evaluation of CALR -mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression.
Br J Haematol
; 188(6): 935-944, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31710700
4.
WT1 gene is overexpressed in myeloproliferative neoplasms, especially in myelofibrosis.
Blood Cells Mol Dis
; 75: 35-40, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30612065
5.
Sequential analysis of 18 genes in polycythemia vera and essential thrombocythemia reveals an association between mutational status and clinical outcome.
Genes Chromosomes Cancer
; 56(5): 354-362, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27997717
6.
Histological and genetic characterization and follow-up of 130 patients with chronic triple-negative thrombocytosis.
Haematologica
; 107(11): 2725-2731, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35833299
7.
Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group.
Haematologica
; 102(1): 85-93, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27540137
8.
Different number of circulating CD34 + cells in essential thrombocythemia, prefibrotic/early primary myelofibrosis, and overt primary myelofibrosis.
Ann Hematol
; 101(4): 893-896, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34611719
9.
Concomitant CALR and LNK mutations leading to essential thrombocythemia with erythrocytosis.
Blood Cells Mol Dis
; 71: 75-76, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29703677
10.
Clinical and biological characterization of MPN patients harboring two driver mutations, a French intergroup of myeloproliferative neoplasms (FIM) study.
Am J Hematol
; 93(4): E84-E86, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29266414
11.
Efficacy and safety of ruxolitinib in patients with myelofibrosis and low platelet count (50 × 109/L to <100 × 109/L) at baseline: the final analysis of EXPAND.
Ther Adv Hematol
; 13: 20406207221118429, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36105914
12.
Ruxolitinib before allogeneic hematopoietic transplantation in patients with myelofibrosis on behalf SFGM-TC and FIM groups.
Bone Marrow Transplant
; 56(8): 1888-1899, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33767402
13.
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.
Blood Adv
; 5(5): 1442-1451, 2021 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33666653
14.
Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis.
Histopathology
; 56(6): 758-67, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20546341
15.
Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation.
Blood Adv
; 4(19): 4887-4897, 2020 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33035330
16.
Steroid-resistant minimal change nephrotic syndrome in Waldenström macroglobulinemia.
Ann Hematol
; 92(3): 425-6, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23053184
17.
JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes.
Blood Cancer J
; 12(4): 56, 2022 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35395836
18.
Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs.
Leuk Res
; 63: 34-40, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29096334
19.
Thalidomide versus placebo in myeloid metaplasia with myelofibrosis: a prospective, randomized, double-blind, multicenter study.
Haematologica
; 91(8): 1027-32, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16885042
20.
Long-term follow-up of JAK2 exon 12 polycythemia vera: a French Intergroup of Myeloproliferative Neoplasms (FIM) study.
Leukemia
; 35(3): 871-875, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32694617